What is the Org number of Leo Pharma Aktiebolag?

Leo Pharma Aktiebolag is registered with Bolagsverket / SCB under Org 5560754318.

What is the revenue of Leo Pharma Aktiebolag?

Leo Pharma Aktiebolag reported revenue of SEK 163,4M in 2024.

Leo Pharma Aktiebolag employs 21 people as of the latest annual report.

Klaus Spärck Abel is Chief Executive Officer of Leo Pharma Aktiebolag, in role since 2020.

Catherine Thérèse Jeanne Mazzacco Beaudoin chairs the board of Leo Pharma Aktiebolag, in role since 2020.

Leo Pharma Aktiebolag's registered address is Hyllie Stationstorg 31.

ABActive

Org 5560754318Hyllie Stationstorg 31, 215 32 MalmöWholesale of pharmaceutical and medical goods · NACE 4646Est. 196021 employees

Actively employed in the business

Name	Role	Member since
Current (3)
MP Maria Pernilla Rehnberg Chief Auditor	Chief Auditor	2020
SD Simon David Besjakov Authorized Recipient of Service	Authorized Recipient of Service	2025
AC Anja Cecilie Verhaug Chief Executive Officer	Chief Executive Officer	2022
Former (4)
KS Klaus Spärck Abel Chief Executive Officer	Chief Executive Officer	2020 – 2021
HÅ Hans Åke Karl Petersson Authorized Recipient of Service	Authorized Recipient of Service	2020 – 2025
NS Nicolai Salgaard Bendtsen Chief Executive Officer	Chief Executive Officer	2021 – 2021
CB Christian Bruun-Andersen Chief Executive Officer	Chief Executive Officer	2021 – 2022

Non-executive oversight

Name	Role	Member since
Current (2)
KD Kücükkose Dilay	Chairman	2025
JG Jakob Gregersen	Deputy Board Member	2024
Former (6)
CT Catherine Thérèse Jeanne Mazzacco Beaudoin	Chairman	2020 – 2022
JH Jannie Holm	Chairman	2022 – 2024
KD Kim Domela Kjoller	Deputy Board Member	2020 – 2021
AK Anders Kronborg	Board of Directors	2020 – 2022
AJ Anders John Krüger	Chairman	2024 – 2025
MS Monica Shaw	Deputy Board Member	2021 – 2022

As of last annual report

Shareholder	Type	Ownership	Votes	Since
LEO PHARMA A/S	Company	100%	100%	2025

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.